Navigation Links
Cystic Fibrosis Foundation announces positive early results for phase 2 clinical trial of VX-770
Date:3/27/2008

when the model of venture philanthropy was wholly untested, the Cystic Fibrosis Foundation was willing to take a chance that Vertexs CF program would yield meaningful results for people with cystic fibrosis, said Joshua Boger, Ph.D., president and CEO of Vertex Pharmaceuticals. The project carried significant risk that would have dissuaded many companies and investors from moving forward. Today, however, with the Foundations financial, scientific and clinical network support, we have been able to bring two novel CF compounds into development and are encouraged by these early results for VX-770.

Overall, the Foundation has invested nearly $300 million in CF drug research with dozens of biotech collaborators nationwide. These collaborations with for-profit companies are part of the Foundations unique venture philanthropy business model. The model, which is being emulated by other orphan disease organizations, has spawned a drug pipeline of more than 30 therapies in development.

Part One of the Phase 2a trial of VX-770 studied 20 cystic fibrosis patients over a 14-day period. Part Two of the study is expected to begin in the second quarter of 2008. Additional studies will evaluate the longer-term safety and efficacy of the compound.

Cystic fibrosis is a life-threatening genetic disease that affects about 30,000 people in the United States and 70,000 worldwide. CF is caused by a genetic mutation that results in a malfunctioning (or missing) protein that results in an imbalance of salt and water. This imbalance causes a cascade of mucus plugging, infection and inflammation in the lungs and other organs. The primary cause of death in CF is lung disease.

The predicted median age of survival for people with CF is age 37 more than double what it was 25 years ago.


'/>"/>

Contact: Laurie Fink
lfink@cff.org
301-841-2602
Cystic Fibrosis Foundation
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Ibuprofen can slow lung disease in children with cystic fibrosis, Canadian study shows
2. Anaheim to Host Worlds Largest Cystic Fibrosis Medical Meeting
3. AMRI and Cystic Fibrosis Foundation Launch Major Research Collaboration
4. Cystic Fibrosis Foundation Named Charitable Organization of the Year by USA Track & Field
5. Cystic Fibrosis foundation lays out new treatment guidelines
6. Experts Release New Cystic Fibrosis Guidelines
7. Lung Transplants May Not Help Most Cystic Fibrosis Children
8. Ibuprofen associated with slower lung function decline in children with cystic fibrosis
9. Ibuprofen Preserves Lung Function in Kids With Cystic Fibrosis
10. Montana Passes Newborn Screening Law for Cystic Fibrosis
11. Cystic Fibrosis Foundation reports upward trend for key health outcomes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... ... September 04, 2015 , ... On the ... effectively doubled the size of its annual health tech innovation program. Now featuring ... health startups to compete for cash and prizes to advance their technologies toward ...
(Date:9/4/2015)... ... September 04, 2015 , ... IVF New England, one of the largest ... "ManchVegas Happy Hour" in Manchester for women who wish to learn more about their ... Elm restaurant and lounge, 827 Elm Street, Manchester, NH from 6PM to 7PM , ...
(Date:9/4/2015)... , ... September 04, 2015 , ... ... three separate “Partner of the Year” awards at this year’s Microsoft Worldwide Partner ... Microsoft’s 2015 “Partner of the Year” Award Winner for Data Platform services, the ...
(Date:9/4/2015)... Pittsburgh, PA (PRWEB) , ... September 04, 2015 , ... Many consumers are looking for ... Cups could be their solution. , The patent-pending K Med Cups provide a quick and ... they help to relieve a cold, flu or cough. As a result, they enhance comfort ...
(Date:9/4/2015)... Washington (PRWEB) , ... September 04, 2015 , ... ... design and development of its first neighborhood created specifically for adults with intellectual, ... in the Phoenix Metro area and feature 30 cottage or “pocket” homes. In ...
Breaking Medicine News(10 mins):Health News:Insight Product Development Startup Competition on Track to Double Program Impact 2Health News:Insight Product Development Startup Competition on Track to Double Program Impact 3Health News:IVF New England to Host ManchVegas New Hampshire Fertility Happy Hour on October 15, 2015 in Manchester for Women Who Wish to Learn More About Fertility and Egg Freezing 2Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 2Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 3Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 4Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 4
... who smoke are often the ones who make fewer ... happens in spite of the fact that smoking puts ... ,The finding holds true regardless of age, ... ,The study, reported in the latest American Journal ...
... guru Ravi Shankar's Art of Living methods for a ... in Russia. ,The Art of Living foundation and ... of understanding (MoU) for collaborative research and community healthcare ... visit to Krasnoyarsk from Monday. ,Under the agreement, ...
... the family at home can effectively encourager the ... for children suffering from diseases. ,Researchers from ... counseling could lead to healthier eating habits among ... // ,Genetic predisposition and unhealthy behaviors ...
... of middle-aged women and is characterized by recurring discomfort ... Symptoms vary and can include a combination of mild ... and pelvic area; and an urgent and/or frequent need ... become scarred or irritated, and pinpoint bleeding may appear ...
... a way to print DNA (Deoxyribonucleic Acid), which they ... as blood tests. ,The technique called Supramolecular Nano-Stamping ... not generally used in medical diagnostics.// ,The ... his colleagues at the Massachusetts Institute of Technology (MIT). ...
... University of Texas Medical Branch at Galveston (UTMB) have found ... cause the “mad cow disease” in people. According to their ... that are there in the blood causing the disease.// ... of Nature Medicine. The findings from the study are expected ...
Cached Medicine News:Health News:Marijuana-Derived Drug Promises Hope In Treating Bladder Infection 2
(Date:9/4/2015)... Fair Rate Funding, a lawsuit funding firm located ... dramatic increase in lawsuit filings in connection with the blood ... the Philadelphia Court of Common Pleas ... the Louisiana multi---district litigation (MDL), located ... Louisiana , the filings are also on ...
(Date:9/4/2015)... 2015  Essilor is pleased to announce the launch ... the eyestrain that comes with the constant connection to ... an everyday pair of glasses to provide comfort and ... smart phones, tablets and computers for hours at a ... a prescription but also those who currently wear contact ...
(Date:9/4/2015)... , September 4, 2015 ... by Application (Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Leukapheresis, and Photopheresis) by ... and by Product - Global Forecast to 2020", published ... reach USD 2.5 Billion by 2020, growing at a ... to 2020. Browse 139 Tables and ...
Breaking Medicine Technology:Xarelto Lawsuit Funding Firm, Fair Rate Funding Reports a Steady Rise in Xarelto Product Liability Lawsuit Filings 2Xarelto Lawsuit Funding Firm, Fair Rate Funding Reports a Steady Rise in Xarelto Product Liability Lawsuit Filings 3Essilor Launches New Eyezen Glasses Specifically Designed For A Digital Focused Audience 2Apheresis Market Worth 2.5 Billion USD by 2020 2Apheresis Market Worth 2.5 Billion USD by 2020 3Apheresis Market Worth 2.5 Billion USD by 2020 4Apheresis Market Worth 2.5 Billion USD by 2020 5
... 2, 2011  MedinCell, a leading developer of low-cost, ... for key companion and food animal markets with ... Congress in Kansas City (December 6-8, 2011). ... over the duration of drug release, thereby making ...
... (NASDAQ: STXS ) today announced that executive ... be held on December 13-14, 2011 in New York. Michael ... is scheduled to present an overview of the Company ... A live webcast and subsequent archived ...
Cached Medicine Technology:MedinCell to Explore Controlled-Release Drug Delivery Partnerships at the World Animal Health Congress 2Stereotaxis to Present at the Oppenheimer Healthcare Conference on December 13, 2011 2Stereotaxis to Present at the Oppenheimer Healthcare Conference on December 13, 2011 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: